Immutep Ltd ADR
Price & Volume
Stats
See more52W Range | $1.32-$3.31 |
Market Cap | $434.2M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $5M |
Revenue Growth (YoY) | 9.5% |
Gross Profit (12 Mos) | -$56.3M |
Diluted EPS | -$0.45 |
News
See moreYahoo Finance • 20 days ago
Immutep Announces Positive Update on IMP761, a First-in-Class LAG-3 Agonist Antibody for Autoimmune Diseases, from Phase I Study
Yahoo Finance • 26 days ago
Immutep Announces Strong Operational Progress in Global TACTI-004 (KEYNOTE-F91) Phase III and Enrolment Continues at Robust Pace
Yahoo Finance • 27 days ago
Immutep (IMMP) Scores Win After Announcing Deal With Indian Firm
Yahoo Finance • last month
Immutep Limited (IMMP): Firm Reports Positive Data from Trials
About
CEO | Mr. Marc Voigt |
CFO | Mr. Marc Voigt |
Address | Australia Square, Sydney, NSW, Australia, 2000 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |
